Clinical Trial Update: An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis [Phase 1, Phase 2]

View source ↗

Summary

An open-label pilot study evaluating everolimus with external beam radiotherapy for neuroendocrine tumor liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Neuroendocrine
• Neuroendocrine Tumors

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Carcinoma, Neuroendocrine | Phase 1, Phase 2 | Status: COMPLETED